| Literature DB >> 28841913 |
M Fernández-Sampedro1, C Fariñas-Alvarez2, C Garces-Zarzalejo3, M A Alonso-Aguirre3, C Salas-Venero4, L Martínez-Martínez4, M C Fariñas5.
Abstract
BACKGROUND: A combination of laboratory, histopathological and microbiological tests for diagnosis of prosthetic joint infection (PJI) have been strongly recommended. This study aims to characterize the accuracy of individual or group tests, such as culture of sonicate fluid, synovial fluid and peri-implant tissue, C-reactive protein (CRP) and histopathology for detection of early, delayed and late PJI.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28841913 PMCID: PMC6389211 DOI: 10.1186/s12879-017-2693-1
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Characteristics of patients with prosthetic joint infection
| Early (< 3 months) | Delayed (3–12 months) | Late (>12 months) |
| |
|---|---|---|---|---|
| Demographics | ||||
| Mean age (yrs) (IQR)** | 65.05 (42–83) | 62.2 (31–84) | 67.2 (33–88) | 0.088 |
| Gender Female-no (%) | 8 (44.4%) | 20 (57.1%) | 36 (46.7%) | 0.540 |
| Type of implant | ||||
| Knee -no (%) | 3 (16.7%) | 14 (40%) | 29 (37.7%) | |
| Hip-no (%) | 15 (83.3%) | 21 (60%) | 48 (62.3%) | 0.196 |
| Antibiotic prior to revision surgery-no (%) | 10 (55%) | 6 (17.1%) | 9 (11.6%) | <0.0001 |
| Type of surgery | 0.081 | |||
| Two stage revision | 6 (33.3%) | 21 (60%) | 43 (55.8%) | |
| One stage revision | 1 (5.5%) | 5 (14.3%) | 9 (11.7%) | |
| Partial revision | 11 (61.2%) | 7 (20%) | 24 (31.2%) | |
| Girdlestone | 0 | 2 (5.7%) | 1 (1.3%) | |
yrs years
*Two-tailed ANOVA test, χ2 test or Fisher exact test as corresponding
**IQR interquartile range
Comparison of sensitivity, specificity, PPV, and NPV for individual parameters in 498 patients with aseptic loosening and prosthetic joint infection (18 early, 35 delayed and 77 late)
| Diagnostic test | AL | PJI | Specificity (%) | Sensitivity (%) | PPV (%) | NPV (%) | ROC área (95% CI) |
|
|---|---|---|---|---|---|---|---|---|
| TN/total | TP/total | (95% CI) | (95% CI) | (95% CI) | (95% CI) | |||
| CRP (>1) | ||||||||
| All patients | 310/367 | 90/128 | 84.5 (80.4–88.0) | 70.3 (61.6–78.1) | 61.2 (52.8–69.1) | 89.1 (85.3–92.2) | 0.774 (0.730–0.818) | 0.124 |
| Early | 10/13 | 13/16 | 76.9 (46.2–95.0) | 81.3 (54.4–96.0) | 81.3 (54.4–96.0) | 76.9 (46.2–95.0) | 0.791 (0.636–0.946) | |
| Delayed | 20/23 | 29/35 | 87.0 (66.4–97.2) | 82.9 (66.4–93.4) | 90.6 (75.0–98.0) | 76.9 (56.4–91.0) | 0.849 (0.754–0.943) | |
| Late | 280/331 | 48/77 | 84.6 (80.2–88.3) | 62.3 (50.6–73.1) | 48.5 (38.3–58.7) | 90.6 (86.8–93.6) | 0.735 (0.678–0.792) | |
| Synovial fluid culture | ||||||||
| All patients | 310/310 | 53/116 | 100 (98.8–100) | 45.7 (36.4–55.2) | 100 (93.3–100) | 83.1 (78.9–86.8) | 0.728 (0.683–0.774) | 0.039 |
| Early | 13/13 | 9/16 | 100 (75.3–100) | 56.3 (29.9–80.2) | 100 (66.4–100) | 65.0 (40.8–84.6) | 0.781 (0.656–0.906) | |
| Delayed | 18/18 | 20/33 | 100 (81.5–100) | 60.6 (42.1–77.1) | 100 (83.2–100) | 58.1 (39.1–75.5) | 0.803 (0.718–0.888) | |
| Late | 279/279 | 24/67 | 100 (98.7–100) | 35.8 (24.5–48.5) | 100 (85.8–100) | 86.6 (82.4–90.2) | 0.679 (0.621–0.736) | |
| Peri-implant tissue culture | ||||||||
| All patients | 367/368 | 81/130 | 99.7 (98.5–100) | 62.3 (53.4–70.7) | 98.8 (93.4–100) | 88.2 (84.7–91.2) | 0.810 (0.768–0.852) | 0.033 |
| Early | 13/13 | 15/18 | 100 (75.3–100) | 83.3 (58.6–96.4) | 100 (78.2–100) | 81.3 (54.4–96.0) | 0.917 (0.828–1.000) | |
| Delayed | 24/24 | 23/35 | 100 (85.8–100) | 65.7 (47.8–80.9) | 100 (85.2–100) | 66.7 (49.0–81.4) | 0.829 (0.749–0.908) | |
| Late | 330/331 | 43/77 | 99.7 (98.3–100) | 55.8 (44.1–67.2) | 97.7 (88.0–99.9) | 90.7 (87.2–93.4) | 0.778 (0.722–0.834) | |
| Sonicate fluid culture | ||||||||
| All patients | 366/368 | 110/130 | 99.5 (98.1–99.9) | 84.6 (77.2–90.3) | 98.2 (93.7–99.8) | 94.8 (92.1–96.8) | 0.920 (0.889–0.952) | 0.402 |
| Early | 13/13 | 15/18 | 100 (75.3–100) | 83.3 (58.6–96.4) | 100 (78.2–100) | 81.3 (54.4–96.0) | 0.917 (0.828–1.000) | |
| Delayed | 23/24 | 33/35 | 95.8 (78.8–99.9) | 94.3 (80.8–99.3) | 97.1 (84.7–99.9) | 92.0 (74.0–99.0) | 0.951 (0.894–1.000) | |
| Late | 330/331 | 62/77 | 99.7 (98.3–100) | 80.5 (69.9–88.7) | 98.4 (91.5–100) | 95.7 (92.9–97.5) | 0.901 (0.856–0.946) | |
| Histology | ||||||||
| All patients | 368/368 | 100/128 | 100 (99.0–100) | 78.1 (70.0–84.9) | 100 (96.4–100) | 92.9 (89.9–95.3) | 0.891 (0.855–0.927) | 0.190 |
| Early | 13/13 | 14/18 | 100 (75.0–100) | 77.8 (52.4–93.6) | 100 (76.8–100) | 76.5 (50.1–93.2) | 0.889 (0.790–0.987) | |
| Delayed | 24/24 | 29/33 | 100 (85.8–100) | 87.9 (71.8–96.6) | 100 (88.1–100) | 85.7 (67.3–95.9) | 0.939 (0.883–0.996) | |
| Late | 331/337 | 57/77 | 100 (98.9–100) | 74.0 (62.8–83.4) | 100 (93.7–100) | 94.3 (91.3–96.4) | 0.870 (0.821–0.919) | |
AL aseptic loosening, PJI prosthetic joint infection, TN true negative, TP true positive, CI confidence interval, PPV positive predictive value, NPV negative predictive value, CRP C-reactive protein
*Two sided P-value Test of equality of independent ROC areas in the three groups of patients with PJI: early, delayed and late
Diagnostic Accuracy for Grouped Parameters in 498 Patients with Aseptic Loosening and Prosthetic Joint Infection (18 early, 35 delayed and 77 late)
| AL | PJI | Specificity (%) | Sensitivity (%) | PPV (%) | NPV (%) | ROC area |
| |
|---|---|---|---|---|---|---|---|---|
| TN/total | TP/total | (95% CI) | (95% CI) | (95% CI) | (95% CI) | (95% CI) | ||
| CRP + Synovial fluid culture | ||||||||
| All patients | 261/309 | 91/114 | 84.5 (79.9–88.3) | 79.8 (71.3–86.8) | 65.5 (56.9–73.3) | 91.9 (88.1–94.8) | 0.822 (0.779–0.863) | 0.073 |
| Early | 10/13 | 12/14 | 76.9 (46.2–95.0) | 85.7 (57.2–98.2) | 80.0 (51.9–95.7) | 83.3 (51.6–97.9) | 0.813 (0.660–0.966) | |
| Delayed | 14/17 | 30/33 | 82.4 (56.6–96.2) | 90.9 (75.7–98.1) | 90.9 (75.7–98.1) | 82.4 (56.6–96.2) | 0.866 (0.760–0.972) | |
| Late | 237/279 | 49/67 | 84.9 (80.2–88.9) | 73.1 (60.9–83.2) | 53.8 (43.1–64.4) | 92.9 (89.1–95.8) | 0.790 (0.733–0.848) | |
| CRP + Peri-implant tissue culture | ||||||||
| All patients | 310/367 | 110/128 | 84.5 (80.4–88.0) | 85.9 (78.7–91.4) | 65.9 (58.1–73.0) | 94.5 (91.5–96.7) | 0.852 (0.817–0.888) | 0.331 |
| Early | 10/13 | 16/16 | 76.9 (46.2–95.0) | 100 (79.4–100) | 84.2 (60.4–96.6) | 100 (69.2–100) | 0.885 (0.765–1.000) | |
| Delayed | 20/23 | 32/35 | 87.0 (66.4–97.2) | 91.4 (76.9–98.2) | 91.4 (76.9–98.2) | 87.0 (66.4–97.2) | 0.892 (0.807–0.977) | |
| Late | 280/331 | 62/77 | 84.6 (80.2–88.3) | 80.5 (69.9–88.7) | 54.9 (45.2–64.2) | 94.9 (91.8–97.1) | 0.826 (0.777–0.874) | |
| CRP + Sonicate fluid culture | ||||||||
| All patients | 309/367 | 119/128 | 84.2 (80.1–87.8) | 93.0 (87.1–96.7) | 67.2 (59.8–74.1) | 97.2 (94.7–98.7) | 0.886 (0.857–0.915) | 0.532 |
| Early | 10/13 | 15/16 | 76.9 (46.2–95.0) | 93.8 (69.8–99.8) | 83.3 (58.6–96.4) | 90.9 (58.7–99.8) | 0.853 (0.719–0.987) | |
| Delayed | 20/23 | 34/35 | 87.0 (66.4–97.2) | 97.1 (85.1–99.9) | 91.9 (78.1–98.3) | 95.2 (76.2–99.9) | 0.921 (0.845–0.996) | |
| Late | 279/331 | 70/77 | 84.3 (79.9–88.0) | 90.9 (82.2–96.3) | 57.4 (48.1–66.3) | 97.6 (95.0–99.0) | 0.876 (0.838–0.914) | |
| Histology + Peri-implant tissue culture | ||||||||
| All patients | 367/368 | 123/128 | 99.7 (98.5–100) | 96.1 (91.1–98.7) | 99.2 (95.6–100) | 98.7 (96.9–99.6) | 0.979 (0.962–0.996) | 0.061 |
| Early | 13/13 | 18/18 | 100 (75.3–100) | 100 (81.5–100) | 100 (81.5–100) | 100 (75.3–100) | 1.000 (1.000–1.000) | |
| Delayed | 24/24 | 32/33 | 100 (85.8–100) | 97.0 (84.2–99.9) | 100 (89.1–100) | 96.0 (79.6–99.9) | 0.985 (0.955–1.000) | |
| Late | 330/331 | 73/77 | 99.7 (98.3–100) | 94.8 (87.2–98.6) | 98.6 (92.7–100) | 98.8 (97.0–99.7) | 0.973 (0.947–0.998) | |
| Histology + Sonicate fluid culture | ||||||||
| All patients | 366/368 | 128/128 | 99.5 (98.1–99.9) | 100 (97.2–100) | 98.5 (94.3–99.8) | 100 (99.0–100) | 0.997 (0.993–1.000) | 0.37 |
| Early | 13/13 | 18/18 | 100 (75.3–100) | 100 (81.5–100) | 100 (81.5–100) | 100 (75.3–100) | 1.000 (1.000–1.000) | |
| Delayed | 23/24 | 33/34 | 95.8 (78.9–99.9) | 100 (89.4–100) | 97.1 (84.7–99.9) | 100 (85.2–100) | 0.978 (0.938–1.000) | |
| Late | 330/331 | 77/77 | 99.7 (98.3–100) | 100 (95.3–100) | 98.7 (93.1–100) | 100 (98.9–100) | 0.999 (0.996–1.000) | |
| Peri-implant tissue culture + Sonicate fluid culture | ||||||||
| All patients | 365/368 | 111/130 | 99.2 (97.6–99.8) | 85.4 (78.1–91.0) | 97.4 (92.5–99.5) | 95.1 (92.4–97.0) | 0.923 (0.892–0.954) | 0.32 |
| Early | 13/13 | 16/18 | 100 (75.3–100) | 88.9 (65.3–98.6) | 100 (79.4–100) | 86.7 (59.5–98.4) | 0.945 (0.870–1.000) | |
| Delayed | 23/24 | 33/34 | 95.8 (78.9–99.9) | 94.3 (80.8–99.3) | 97.1 (84.7–99.9) | 92.0 (74.0–99.0) | 0.951 (0.894–1.000) | |
| Late | 329/331 | 62/77 | 99.4 (97.8–99.9) | 80.5 (69.9–88.7) | 96.9 (96.2–99.6) | 95.6 (92.9–97.5) | 0.900 (0.855–0.944) | |
AL aseptic loosening, PJI prosthetic joint infection, TN true negative, TP true positive, CI confidence interval, PPV positive predictive value, NPV negative predictive value, CRP C-reactive protein
*Two sided P-value Test of equality of independent ROC areas in the three groups of patients with PJI: early, delayed and late